GBSG — Intelligent Bio Solutions Balance Sheet
0.000.00%
Last trade - 00:00
HealthcareMicro Cap
- $7.28m
- $6.64m
- $1.26m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS/A | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.198 | 0.427 | 12.6 | 8.24 | 1.54 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.095 | 0.02 | 3.21 | 2.47 | 0.833 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2.33 | 2.34 | 18.2 | 10.9 | 3.86 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | — | — | 0.391 | 1.24 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 2.33 | 2.48 | 21.9 | 12.4 | 10.4 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6.31 | 7.69 | 3.68 | 4.66 | 5.88 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 6.94 | 7.66 | 6.8 | 5.73 | 6.56 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | -4.62 | -5.19 | 15.1 | 6.62 | 3.8 |
Total Liabilities & Shareholders' Equity | 2.33 | 2.48 | 21.9 | 12.4 | 10.4 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |